CollPlant Biotechnologies Ltd (CLGN) — Institutional Holders, Q2 2026
16 institutional investment managers reported a CLGN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $582.4K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CLGN in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- PINNACLE ASSOCIATES LTDAdded · +181,434 sh+$63.3K
- RENAISSANCE TECHNOLOGIESAdded · +44,700 sh+$15.6K
- CITADEL ADVISORSAdded · +21,535 sh+$7.5K
- UBS Group AGAdded · +940 sh+$328.00
- Strive Financial GroupNew · +169 sh+$59.00
Biggest sellers
- ARMISTICE CAPITALSold out · -64,000 sh-$22.3K
- BROWN ADVISORYTrimmed · -14,000 sh-$4.9K
- Virtu FinancialSold out · -12,600 sh-$4.4K
- TWO SIGMA SECURITIESSold out · -11,357 sh-$4.0K
- XTX Topco LtdTrimmed · -1,714 sh-$598.00
CLGN 13F holders ranked 1–16 of 16
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | PINNACLE ASSOCIATES LTD#1 · 731,663 sh | 731,663 | $255.3K | — | +33.0% |
| 2 | VILLERE ST DENIS J#2 · 606,400 sh | 606,400 | $211.6K | 0.03% | -0.1% |
| 3 | BROWN ADVISORY#3 · 104,731 sh | 104,731 | $36.5K | <0.01% | -11.8% |
| 4 | RENAISSANCE TECHNOLOGIES#4 · 61,500 sh | 61,500 | $21.5K | 0.00% | +266.1% |
| 5 | Pathstone#5 · 57,000 sh | 57,000 | $19.9K | <0.01% | 0.0% |
| 6 | CITADEL ADVISORS#6 · 53,700 sh | 53,700 | $18.7K | 0.00% | +67.0% |
| 7 | Legacy Wealth Managment#7 · 23,179 sh | 23,179 | $8.1K | <0.01% | 0.0% |
| 8 | WATERS PARKERSON#8 · 13,250 sh | 13,250 | $4.6K | <0.01% | 0.0% |
| 9 | XTX Topco Ltd#9 · 13,081 sh | 13,081 | $4.6K | <0.01% | -11.6% |
| 10 | FNY Investment Advisers#10 · 5,250 sh | 5,250 | $1.0K | — | -0.9% |
| 11 | UBS Group AG#11 · 1,035 sh | 1,035 | $361.00 | 0.00% | +989.5% |
| 12 | OSAIC#12 · 345 sh | 345 | $120.00 | 0.00% | 0.0% |
| 13 | SBI Securities , Ltd.#13 · 200 sh | 200 | $70.00 | — | 0.0% |
| 14 | Strive Financial Group#14 · 169 sh | 169 | $59.00 | 0.00% | New |
| 15 | Parallel Advisors#15 · 71 sh | 71 | $25.00 | 0.00% | 0.0% |
| 16 | MORGAN STANLEY#16 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
Funds that sold out of CLGN in Q2 2026 (6)
Held CLGN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| ARMISTICE CAPITAL64,000 sh | 64,000 | $34.3K |
| Virtu Financial12,600 sh | 12,600 | $7.0K |
| TWO SIGMA SECURITIES11,357 sh | 11,357 | $6.1K |
| GROUP ONE TRADING, L.P.1,400 sh | 1,400 | $749.00 |
| WELLS FARGO & COMPANY300 sh | 300 | $161.00 |
| SIMPLEX TRADING118 sh | 118 | $63.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.